Proliferation of central clearing in Asia causes tech trials

The introduction of central counterparty (CCPs) clearing for over-the-counter derivatives poses significant technological challenges for dealers, end-users and the CCPs themselves. How are they coping? Clive Davidson reports

technology arms race

Among the key measures proposed by the Group of 20 in response to the financial crisis is reform of the over-the-counter derivatives market, including the introduction of central clearing for standardised instruments. The US was the first to implement this recommendation, followed by Europe, while Asia is following suit. So far, Japan and Hong Kong have taken steps towards mandating the central clearing of certain OTC derivatives, with Singapore, Australia, South Korea and other countries

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

AI wide open

The Risk Technology Awards 2018 have highlighted how new technologies are bringing recognition for vendors

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here